Citation: Mej. Newman et R. Engelhardt, EFFECTS OF SELECTIVE NEUTRALITY ON THE EVOLUTION OF MOLECULAR-SPECIES, Proceedings - Royal Society. Biological Sciences, 265(1403), 1998, pp. 1333-1338
Authors:
BRUGGER W
DIERKESMANN R
TOOMES H
ENGELHARDT R
HASSE J
PRESSLER K
KOLLMANNSBERGER C
SCHUMACHER M
FROMMHOLD H
BAMBERG M
KANZ L
Citation: W. Brugger et al., MULTICENTER RANDOMIZED PHASE-III STUDY EVALUATING THE ROLE OF HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER, Onkologie, 21, 1998, pp. 12-14
Authors:
BRUGGER W
FETSCHER S
HASSE J
FROMMHOLD H
PRESSLER K
MERTELSMANN R
ENGELHARDT R
KANZ L
Citation: W. Brugger et al., MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 42-48
Citation: R. Engelhardt, VERY LITTLE MONEY YIELDS VERY LITTLE - HO FMANN,RAINER OF HAMBURG DEVELOPS SURVIVAL STRATEGIES FOR THE ORTHOPEDIC PRACTICE, Zeitschrift fur Orthopadie und Ihre Grenzgebiete, 136(2), 1998, pp. 16-17
Authors:
STEHR K
CHERRY JD
HEININGER U
SCHMITTGROHE S
UBERALL M
LAUSSUCQ S
ECKHARDT T
MEYER M
ENGELHARDT R
CHRISTENSON P
Citation: K. Stehr et al., A COMPARATIVE EFFICACY TRIAL IN GERMANY IN INFANTS WHO RECEIVED EITHER THE LEDERLE TAKEDA ACELLULAR PERTUSSIS COMPONENT DTP (DTAP) VACCINE,THE LEDERLE WHOLE-CELL COMPONENT DTP VACCINE, OR DT VACCINE/, Pediatrics, 101(1), 1998, pp. 1-11
Authors:
ENGELHARDT R
TURCK V
POHL UW
BIMBERG D
VEIT P
Citation: R. Engelhardt et al., 3-DIMENSIONALLY CONFINED EXCITONS IN MOCVD-GROWN ULTRATHIN CDSE DEPOSITIONS IN ZNSSE MATRIX, Journal of crystal growth, 185, 1998, pp. 311-314
Authors:
KUTTLER M
STRASSBURG M
TURCK V
ENGELHARDT R
POHL UW
BIMBERG D
BEHRINGER M
HOMMEL D
NURNBERGER J
LANDWEHR G
Citation: M. Kuttler et al., EFFICIENT LATERAL INDEX GUIDING OF II-VI LASER STRUCTURES BY IMPLANTATION-INDUCED DISORDERING, Journal of crystal growth, 185, 1998, pp. 566-570
Authors:
FETSCHER S
FINKE J
ENGELHARDT R
MERTELSMANN R
LANGE W
Citation: S. Fetscher et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES, HEM CELL TH, 39(2), 1997, pp. 79-83
Authors:
ASIYOVOGEL MN
KOOP N
BRINKMANN R
ENGELHARDT R
EGGERS R
BIRNGRUBER R
VOGEL A
Citation: Mn. Asiyovogel et al., EVALUATION OF LTK LESIONS BY OPTICAL LOW- COHERENCE TOMOGRAPHY (OCT) AND POLARIZATION MICROSCOPY AFTER SIRIUS-RED STAINING, Der Ophthalmologe, 94(7), 1997, pp. 487-491
Authors:
FETSCHER S
FINKE J
ENGELHARDT R
MERTELSMANN R
LANGE W
Citation: S. Fetscher et al., EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Annals of hematology, 74(2), 1997, pp. 73-77
Authors:
BURGER JA
OCHS A
WIRTH K
BERGER DP
MERTELSMANN R
ENGELHARDT R
ROESSLE M
HAAG K
Citation: Ja. Burger et al., THE TRANSJUGULAR STENT IMPLANTATION FOR THE TREATMENT OF MALIGNANT PORTAL AND HEPATIC VEIN OBSTRUCTION IN CANCER-PATIENTS, Annals of oncology, 8(2), 1997, pp. 200-202
Authors:
FETSCHER S
BRUGGER W
ENGELHARDT R
KANZ L
HASSE J
FROMMHOLD H
WENGER M
LANGE W
MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 49-56
Authors:
FETSCHER S
BRUGGER W
ENGELHARDT R
KANZ L
HASSE J
FROMMHOLD H
WENGER M
LANGE W
MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 57-64
Authors:
DADGAR A
ENGELHARDT R
KUTTLER M
BIMBERG D
Citation: A. Dadgar et al., CAPACITANCE TRANSIENT STUDY OF THE DEEP FE ACCEPTOR IN INDIUM-PHOSPHIDE, Physical review. B, Condensed matter, 56(16), 1997, pp. 10241-10248
Authors:
KIANI A
TSCHIERSCH A
GABORIAU E
OTTO F
SEIZ A
KNOPF HP
STUTZ P
FARBER L
HAUS U
GALANOS C
MERTELSMANN P
ENGELHARDT R
Citation: A. Kiani et al., DOWN-REGULATION OF THE PROINFLAMMATORY CYTOKINE RESPONSE TO ENDOTOXINBY PRETREATMENT WITH THE NONTOXIC LIPID-A ANALOG-SDZ-MRL-953 IN CANCER-PATIENTS, Blood, 90(4), 1997, pp. 1673-1683